FTCM
LVACW

Fir Tree Capital Management’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Fir Tree Capital Management’s Portfolio LVACW Stock Details LVACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-72,354
Closed -$8K – 630
2022
Q2 		$8K Sell
72,354
-242
-0.3% -$49 ﹤0.01% 686
2022
Q1 		$23K Sell
72,596
-2,404
-3% -$974 ﹤0.01% 687
2021
Q4 		$43K Buy
+75,000
New +$38.5K ﹤0.01% 683

Other funds holding LVACW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Fir Tree Capital Management's LVACW Position: Q3 2022 in Review

Fir Tree Capital Management sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q3 2022, closing a stake of 72,354 shares — an estimated $8K sold.

Fir Tree Capital Management first reported a position in LVACW in Q4 2021 and held it in 3 quarters. The position peaked at $43K in Q4 2021. 31 funds tracked by Wall St. Rank hold LVACW as of Q3 2022.

  • Fir Tree Capital Management reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q3 2022 after selling out during the quarter.
  • Fir Tree Capital Management sold 72,354 LAVA Medtech Acquisition Corp. Warrants shares in Q3 2022, an estimated $8K.
  • Fir Tree Capital Management first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q4 2021 and held it in 3 quarters.
  • Fir Tree Capital Management's LAVA Medtech Acquisition Corp. Warrants position peaked at $43K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q3 2022.

Based on Fir Tree Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.